A team of scientists has developed an advanced technique based on chemical “barcodes,” which are small markers left on DNA when stem cells divide. Using this technique, it has become possible to track each stem cell and its fate over time, whether in humans or animals.
Studies have shown that the original reservoir of blood stem cells gradually diminishes after the age of forty-five. Instead of having a large diversity of these cells, a small group begins to dominate. This shift leads to a reduction in the diversity of produced cells and an increase in inflammation-related cells — a phenomenon known as “inflammaging.”
This technique allows doctors to monitor cellular changes early, even before disease symptoms appear. It is believed that this could aid in early intervention or even the regeneration of stem cells to maintain health with aging. Despite this significant step, there is still a need for a deeper understanding of how each type of stem cell affects the body.
🧠 Stem Cell Transplantation for Parkinson’s Disease: A Safe Start and New Hope
Recent clinical trials have been conducted on Parkinson’s disease patients to test the transplantation of stem cells that were converted into dopamine-producing cells in the brain. The experiment relied on using cells taken from the same patient, which reduces the risk of rejection by the immune system.
Over more than a year, the trial showed that the procedure is safe and did not lead to serious complications such as bleeding or tumor formation. Medical imaging also showed that the transplanted cells survived in the brain and began producing dopamine effectively.
The results revealed significant improvement in some patients’ motor functions, such as balance and reduced tremors — especially in cases where higher doses of transplanted cells were used. These developments offer great hope for improving the quality of life for people living with Parkinson’s and pave the way for larger trials involving more participants in the near future.
